"Government offered all assistance to have them supply and or manufacture their vaccines in India," the government said in a statement. "No application of any foreign manufacturer for approval is pending with the drugs controller."India has held talks with Pfizer, Johnson Johnson, Moderna for COVID-19 vaccines
"Government offered all assistance to have them supply and or manufacture their vaccines in India," the government said in a statement. "No application of any foreign manufacturer for approval is pending with the drugs controller."
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment